CHICAGO--(BUSINESS WIRE)--CytoCore Inc. (OTCBB:CYOE), the developer of a suite of cost-effective cervical cell collection devices for the early detection of cancer and sexually transmitted diseases, today reported continued progress during its second quarter ended June 30, 2008.
